Finjan Signs Licensing Agreement With Avast Software

Press Releases |

EAST PALO ALTO, CA--(Nov 16, 2015) -  Finjan Holdings, Inc. (FNJN) , a cybersecurity company, today announced that on November 15, 2015, Finjan, Inc. ("Finjan"), a wholly-owned subsidiary of Finjan Holdings, Inc., entered into a Confidential Patent License, Settlement and Release Agreement (the "Agreement"), with Avast Software s.r.o., a company organized and existing under the laws of the Czech Republic ("AVAST"). The terms of the Agreement are confidential.

With its 20 year history in cybersecurity, Finjan's investments in innovation are captured in its rich portfolio of patents that are centered around proactively detecting previously unknown and emerging threats on a behavior-based basis. Finjan welcomes Avast to its growing list of stellar cybersecurity software and technology licensees. 

ABOUT FINJAN
Established nearly 20 years ago, Finjan is a globally recognized leader in cybersecurity. Finjan's inventions are embedded within a strong portfolio of patents focusing on software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan continues to grow through investments in innovation, strategic acquisitions, and partnerships promoting economic advancement and job creation. For more information, please visit www.finjan.com.

Follow Finjan Holdings, Inc.:
Twitter: @FinjanHoldings
LinkedIn: linkedin.com/company/finjan

 

Contact Information

  •  

    Media Contact:
    Nicholas Gaffney
    Zumado Public Relations
    (415) 732-7801
    ngaffney@zumado.com

    Investor Contact:
    Vanessa Winter
    Finjan
    Alan Sheinwald or Valter Pinto
    Capital Markets Group LLC
    (650) 282-3245
    investors@finjan.com

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
FNJN Finjan Holdings Inc. 1.26 0.02 1.61 10,405

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…